'Therapeutic range' for oral anticoagulant therapy

Chest

Volumn 89, Issue 2 SUPPL., 1986, Pages 11S-15S

  Hirsh, J ^a   Deykin, D ^a   Poller, L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

BLEEDING; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DRUG THERAPY; HEART; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; LUNG EMBOLISM; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; RESPIRATORY SYSTEM; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; THERAPY; THROMBOEMBOLISM; VALVULAR HEART DISEASE; VEIN THROMBOSIS;

EID: 0022592523     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.89.2_Supplement.11S     Document Type: Article

References (18)

1. EA Loeliger The optimal therapeutic range in oral anticoagulation history and proposal Thromb Haemost 42 1979 1141 1152
2. L Poller DA Taberner Dosage and control of oral anticoagulants: an international collaborative survey Br J Haematol 51 1982 479 485
3. IS Wright DF Beck CD Marple Myocardial infarction and its treatment with anticoagulants Lancet 1954 92 97
4. CF Moschos PC Wong HS Sise Controlled study of the effective level of long-term anticoagulation JAMA 190 1964 799 805
5. S Zucker MH Cathey PJ Sox EC Paul Standardization of laboratory tests for controlling anticoagulant therapy Am J Pathol 53 1970 348 354
6. L Poller JM Thomson The Manchester comparative reagent HC Hemker EA Loeliger Veltkamp Human blood coagulation 1969 Springer New York 290 295
7. EL Bailey TA Harper PH Pinkerton Therapeutic range of one-stage prothrombin time in control of anticoagulant therapy CMAJ 1971 94
8. ZS Latallo JM Thomson L Poller An evaluation of chromogenic substrates in the control of oral anticoagulant therapy Br J Haematol 47 1981 307 318
9. S Sevitt NG Gallagher Prevention of venous thrombosis and pulmonary embolism in injured patients Lancet 2 1959 981 989
10. DA Taberner L Poller RW Burslem Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep-vein thrombosis Br Med J 1 1978 272 274
11. CW Francis VJ Marder C McCollister Evarts S Yaukoolbodi Two-step warfarin therapy JAMA 249 3 1983 374 378
12. R Hull T Delmore E Genton J Hirsh M Gent D Sackett Warfarin sodium versus low-dose heparin in the long term treatment of venous thrombosis N Engl J Med 301 1979 855 858
13. R Hull T Delmore C Carter J Hirsh E Genton M Gent Adjusted subcutaneous heparin vs warfarin sodium in the long-term treatment of venous thrombosis N Engl J Med 306 1982 189 194
14. R Hull J Hirsh R Jay C Carter C England M Gent Different intensities of anticoagulation in the long term treatment of proximal vein thrombosis N Engl J Med 307 1982 1676 1681
15. CJ Bjerkelund OM Orning The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am J Cardiol 23 1969 208 216
16. Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council Assessment of short-term anticoagulant administration after cardiac infarction Br Med J 1 1969 335 342
17. Anticoagulants in acute myocardial infarction: Results of a cooperative clinical trial JAMA 225 1973 724
18. V Fuster CW Pumphrey MD McGoon Systemic thromboembolism in mural and aortic Starr-Edwards prosthesis: a long term follow-up (10-19 years) Circulation 1982